Amyloid precursor-like protein 2 interacts with claudin-7 and affects ovarian cancer cell survival

Neetu Dahiya1,2

  • 1Laboratory of Molecular Biology & Immunology, NIH, Baltimore, MD 21224, USA.

Future Science OA
|April 8, 2020
PubMed
Abstract

Insights

This study identified Amyloid precursor-like protein 2 (APLP2) interacting with Claudin 7 (CLDN7) in ovarian cancer. APLP2 may play a regulatory role in ovarian cancer progression, mediated by CLDN7.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Previous research identified roles for Claudin 7 (CLDN7) in cell signaling.
  • Understanding protein interactions is crucial for elucidating cancer mechanisms.

Purpose of the Study:

  • To identify proteins that directly interact with CLDN7 in ovarian cancer.
  • To investigate the functional significance of CLDN7 interactions in ovarian cancer.

Main Methods:

  • Yeast two-hybrid system to identify direct protein interactors of CLDN7.
  • Colony formation assay to assess cell survival.
  • Quantitative analysis of APLP2 expression in ovarian cancer tissues and cell lines.

Main Results:

  • Amyloid precursor-like protein 2 (APLP2) was identified as a direct interactor of CLDN7 in the OVCA420 ovarian cancer cell line.
  • APLP2 expression was elevated in ovarian cancer cell lines and tumor tissues compared to non-neoplastic controls.
  • CLDN7 knockdown resulted in increased APLP2 mRNA and protein levels, while APLP2 knockdown reduced ovarian cancer cell survival.

Conclusions:

  • A direct interaction between CLDN7 and APLP2 in ovarian cancer was demonstrated.
  • APLP2 exhibits a novel regulatory role in ovarian cancer, potentially mediated by CLDN7.